Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2003 1
2006 1
2010 2
2011 4
2013 1
2015 1
2016 2
2017 3
2018 2
2019 1
2020 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Taste Alterations During Treatment With Protein Kinase Inhibitors: A Pilot Study.
van der Werf A, de van der Schueren MAE, Rovithi M, Labots M, Hashemi SMS, Langius JAE, Verheul HMW. van der Werf A, et al. Among authors: rovithi m. J Pain Symptom Manage. 2018 Oct;56(4):e1-e4. doi: 10.1016/j.jpainsymman.2018.06.016. Epub 2018 Jul 17. J Pain Symptom Manage. 2018. PMID: 30025935 Free article. No abstract available.
Y2O2S:Eu phosphor screens evaluation.
Giakoumakis GE, Nomicos CD, Skountzos P, Koutroubas S, Zisos A, Yiakoumakis EN, Katsarioti MC, Kaliakatsos JA, Rovithi M, Panayiotakis GS, et al. Giakoumakis GE, et al. Among authors: rovithi m. Med Phys. 1993 Jan-Feb;20(1):79-83. doi: 10.1118/1.597065. Med Phys. 1993. PMID: 8455516
A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group.
Kontopodis E, Hatzidaki D, Varthalitis I, Kentepozidis N, Giassas S, Pantazopoulos N, Vardakis N, Rovithi M, Georgoulias V, Agelaki S. Kontopodis E, et al. Among authors: rovithi m. J Chemother. 2013 Feb;25(1):49-55. doi: 10.1179/1973947812Y.0000000050. J Chemother. 2013. PMID: 23433445 Clinical Trial.
Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial.
Katopodis O, Polyzos A, Kentepozidis N, Giassas S, Rovithi M, Bozionelou V, Kalbakis K, Vamvakas L, Mavroudis D, Georgoulias V. Katopodis O, et al. Among authors: rovithi m. Cancer Chemother Pharmacol. 2011 Feb;67(2):361-8. doi: 10.1007/s00280-010-1329-6. Epub 2010 Apr 29. Cancer Chemother Pharmacol. 2011. PMID: 20428874 Clinical Trial.
18 results